EPG Online Twitter 
EPG Online Blog 
Disease Knowledge Drug Updates
- Enbrel 25 mg powder and solvent for solution for injection
- Sustiva 50 mg, 100 mg and 200 mg Hard Capsules
- Sandostatin LAR
- Difflam Oral Rinse
- Teoptic 1% - Teoptic 2%
- Erythroped A 500 mg Tablets
- Enalapril 5mg Tablets
- Viskaldix Tablets
- Aricept Tablets
- Difflam Cream
- Alfentanil 500 micrograms/ml solution for injection
- Revlimid
- Benadryl Plus Capsules
- Diclomax Retard
- Voltarol Tablets
- Virgan
- DIXARIT (menopausal disorders)
- Rapiscan (regadenoson)
- Neurontin Capsules and Tablets
- Aprovel Film-Coated Tablets (sanofi-aventis Bristol-Myers Squibb SNC)
- Foradil
- Nystatin-Dome Suspension 100,000 I.U./ml
- Meningitec in pre-filled syringe
- Catapres Tablets 100mcg
- Kemadrin 5 mg Tablets
- SECTRAL 400mg tablets
- Sectral 100mg and 200mg
- Eucardic 25mg Tablets
- ALDOMET Tablets 250 mg
- Parvolex 200 mg/ml Concentrate for Solution for Infusion
- Mifegyne
- Pedea 5 mg/ml solution for injection
- Eucardic 12.5mg Tablets
- Qvar 100 Easi-Breathe
- Qvar 50 Easi-Breathe
- Eucardic 6.25mg Tablets
- Qvar MDI 50 micrograms
- Sonata 5 mg hard capsules
- PRO-EPANUTIN
- Xarelto 20mg film-coated tablets
Alzheimer’s Disease
Please note- this EPG Alzheimer's Knowledge Centre is for Doctors and other Healthcare Professionals. Some resources are available for patients and care givers and may be accessed here. Enter the Alzheimer's Disease Knowledge Centre.
Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age.
In the early stages in particular, dementia is often difficult to diagnose, since many symptoms are not recognized as such or are trivialized by the patient. 20% of actual dementia cases are reported to be incorrectly diagnosed as a different disease.
In early dementia the symptoms of Alzheimer’s disease include memory loss, disorientation and confusion. These symptoms are caused by the loss of neurons and worsen with continuous neurodegeneration. The pathology of dementia is not solely the result of a cholinergic deficit. It is known that, chronically and pathologically elevated glutamate concentrations play an important role.
In general two main groups of dementia can be distinguished, requiring different types of treatment:
Depending on the stage of the disease, clinical symptoms of varying intensity dominate. With the progression of AD, treatment is aimed particularly at improving and stabilizing personal everyday functions, so as to keep patients independent for as long as possible.
Enter the Alzheimer's Disease Knowledge Centre
What’s in the Alzheimer's Knowledge Centre?
- Prevalence of Alzheimers
- Symptoms of Alzheimers
- The stages Of Alzheimers
- Types of Dementia
- Disease Progression
- Treatment Options
- Cholinesterae Inhibitors
- NMDA Receptors Antagonists
- Pipeline Treatments
- Downloads
- Clinical Studies
- Useful Links
- Patient Resources
- Tips for Caregivers
- Downloads for Patients
- What the Experts Say
- Active Ingredient & MoA
- Indication & Diagnosis
- Dosage Application
- Evaluating Success
- Side Effects & Interactions
- Prescription & Costs
- Glossary
- References
- EXELON Transdermal Patch
Symptomatic treatment of mild to moderately severe Alzheimer's dementia ... - EBIXA 10 mg/g oral drops, solution
Treatment of patients with moderate to severe Alzheimer's disease ... - RISPERDAL Tablets, Liquid & Quicklet
... disorders. RISPERDAL is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. RISPERDAL is indicated for the short ... - CERETEC
... of abnormalities of regional cerebral blood flow, such as those occurring following stroke and other cerebrovascular disease, epilepsy, Alzheimer's Disease and other forms of dementia, transient ischaemic attack, migraine and tumours of the brain. (ii) Technetium [99mTc] Exametazime Injection is ... - EBIXA 10mg film-coated tablets
Treatment of patients with moderately severe to severe Alzheimers disease ... - Exelon
Symptomatic treatment of mild to moderately severe Alzheimer's dementia. Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's disease
